Home NDC 0049-3920-83 Geodon
Product NDC 0049-3920
Requested package NDC 0049-3920-83
11-digit product format 000493920
Labeler code 0049
Product ID 0049-3920_c717f8ab-3351-4caa-b1fa-86c2fa415189
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ziprasidone mesylate
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAMUSCULAR
Labeler ROERIG
Application NDA020919
Marketing category NDA
Marketing start 2003-12-23
Marketing end 2026-08-31
Substance ZIPRASIDONE MESYLATE
Active strength 20 mg/mL
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0049-3920 0049-3920-83 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0049-3920 0049-3920-83 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020919-001 GEODON ZIPRASIDONE MESYLATE EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020919-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR AP RLD, RS 2002-06-21 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020919-001 GEODON EQ 20MG BASE/ML INJECTABLE / INTRAMUSCULAR RLD, RS 2002-06-21 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020919-001 GEODON EQ 20MG BASE/VIAL POWDER / INTRAMUSCULAR AP RLD, RS 2002-06-21 cb3db0bc1861…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Geodon Active Ingredients# Ingredient, Strength table Ingredient Strength ZIPRASIDONE MESYLATE 20 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 216X081ORU Internal UNII lookup 6UKA5VEJ6X Internal UNII lookup 3X6SAX83JZ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 284548 Internal RxNorm lookup 284549 Internal RxNorm lookup 284550 Internal RxNorm lookup 285127 Internal RxNorm lookup 313776 Internal RxNorm lookup 313777 Internal RxNorm lookup 313778 Internal RxNorm lookup 314286 Internal RxNorm lookup 351223 Internal RxNorm lookup 352228 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0049-3920-01 Geodon 1 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 48 0049-3920-10 Geodon 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 48 0049-3920-20 Geodon 1 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 1 48 0049-3920-83 Geodon 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 48
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ZIPRASIDONE HYDROCHLORIDE ACTIVE INGREDIENT 216X081ORU GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE MESYLATE ACTIVE INGREDIENT 3X6SAX83JZ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE ACTIVE MOIETY 6UKA5VEJ6X GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 LACTOSE INACTIVE INGREDIENT J2B2A4N98G GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 METHANESULFONIC ACID INACTIVE INGREDIENT 12EH9M7279 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE MESYLATE ACTIVE INGREDIENT 3X6SAX83JZ GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 ZIPRASIDONE ACTIVE MOIETY 6UKA5VEJ6X GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 METHANESULFONIC ACID INACTIVE INGREDIENT 12EH9M7279 GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TYA PHARMACEUTICALS] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0049-3920 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION GEODON (ZIPRASIDONE) CAPSULE [ROERIG] 46 Current NDC, Legacy NDC, 4 package rows 20250129_8326928a-2cb6-4f7f-9712-03a425a14c37.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0049-3920-83 00049392083 10 VIAL, SINGLE-DOSE in 1 CARTON (0049-3920-83) > 1 mL in 1 VIAL, SINGLE-DOSE (0049-3920-20) 2003-12-23 0000-00-00 No No Current